Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gleevec
Biotech
JPM25: M&A strategist GSK acquires IDRx for $1B upfront
“We have an opportunity to develop a best-in-class product for patients and move the standard of care ahead after 20 years," GSK CCO Luke Miels said.
Gabrielle Masson
Jan 13, 2025 2:00am
Deciphera CBO Morl talks lines of therapy for kinase inhibitor ripretinib
Jan 11, 2019 11:10am
EpimAb poaches Novartis China cancer chief as CMO
Feb 27, 2018 8:48am
